C-MYC Apoptotic Function is Mediated by NRF-1 Target Genes
Overview
Affiliations
A detailed understanding of the signaling pathways by which c-Myc elicits apoptosis has proven elusive. In the current study, we have evaluated whether the activation of the mitochondrial apoptotic signaling pathway is linked to c-Myc induction of a subset of genes involved in mitochondrial biogenesis. Cytochrome c and other nuclear-encoded mitochondrial genes are regulated by the transcription factor nuclear respiratory factor-1 (NRF-1). The consensus binding sequence (T/C)GCGCA(C/T)GCGC(A/G) of NRF-1 includes a noncanonical CA(C/T)GCG Myc:MAX binding site. In this study, we establish a link between the induction of NRF-1 target genes and sensitization to apoptosis on serum depletion. We demonstrate, by using Northern analysis, transactivation assays, and in vitro and in vivo promoter binding assays that cytochrome c is a direct target of c-Myc. Like c-Myc, NRF-1 overexpression sensitizes cells to apoptosis on serum depletion. We also demonstrate that selective interference with c-Myc induction of NRF-1 target genes by using a dominant-negative NRF-1 prevented c-Myc-induced apoptosis, without affecting c-Myc-dependent proliferation. These results suggest that c-myc expression leads to mitochondrial dysfunction and apoptosis by deregulating genes involved in mitochondrial function.
Proteasome gene expression is controlled by coordinated functions of multiple transcription factors.
Gilda J, Nahar A, Kasiviswanathan D, Tropp N, Gilinski T, Lahav T J Cell Biol. 2024; 223(8).
PMID: 38767572 PMC: 11104393. DOI: 10.1083/jcb.202402046.
USP13: Multiple Functions and Target Inhibition.
Li X, Yang G, Zhang W, Qin B, Ye Z, Shi H Front Cell Dev Biol. 2022; 10:875124.
PMID: 35445009 PMC: 9014248. DOI: 10.3389/fcell.2022.875124.
Popay T, Wang J, Adams C, Howard G, Codreanu S, Sherrod S Elife. 2021; 10.
PMID: 33416496 PMC: 7793627. DOI: 10.7554/eLife.60191.
Anti- cholesterol based lipoplexes as onco-nanotherapeutic agents .
Habib S, Daniels A, Ariatti M, Singh M F1000Res. 2021; 9:770.
PMID: 33391729 PMC: 7745184. DOI: 10.12688/f1000research.25142.2.
Anti- RNAi-Based Onconanotherapeutics.
Habib S, Ariatti M, Singh M Biomedicines. 2020; 8(12).
PMID: 33333729 PMC: 7765184. DOI: 10.3390/biomedicines8120612.